Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Pine Tree Acquisition Prices $100 Million IPO

Pine Tree Acquisition Prices $100 Million IPO

MT newswireMT newswire2026/10/06 13:08

09:08 AM EDT, 10/06/2026 (MT Newswires) -- Pine Tree Acquisition said Tuesday it has priced its $100 million initial public offering of 10 million units at $10 apiece. The blank-check company said the units are expected to list and trade on the Nasdaq Global Market this Tuesday under the ticker symbol, "PAXGU." Pine Tree said that each unit consists of one class A ordinary share and one right worth three-fourths of a share after an initial business combination. Once the securities comprising the units begin trading, the shares and rights are expected to list on Nasdaq under the "PAXG" and "PAXGR" symbols, respectively, the company said. Pine Tree expects the offering to close on Wednesday.

09:08 AM EDT, 10/06/2026 (MT Newswires) -- Pine Tree Acquisition said Tuesday it has priced its $100 million initial public offering of 10 million units at $10 apiece. The blank-check company said the units are expected to list and trade on the Nasdaq Global Market this Tuesday under the ticker symbol, "PAXGU." Pine Tree said that each unit consists of one class A ordinary share and one right worth three-fourths of a share after an initial business combination. Once the securities comprising the units begin trading, the shares and rights are expected to list on Nasdaq under the "PAXG" and "PAXGR" symbols, respectively, the company said. Pine Tree expects the offering to close on Wednesday.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21